Uma Mahadevan

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Management of inflammatory bowel disease in pregnancy
    Susie W Ng
    Department of Gastroenterology, University of California, San Francisco, CA 94122, USA
    Expert Rev Clin Immunol 9:161-73; quiz 174. 2013
  2. ncbi Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease
    Uma Mahadevan
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, California 94115, USA
    Clin Gastroenterol Hepatol 11:286-92; quiz e24. 2013
  3. ncbi The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics
    Uma Mahadevan
    Department of Gastroenterology, UCSF Center for Colitis and Crohn s Disease, San Francisco, California 94115, USA
    Am J Gastroenterol 106:214-23; quiz 224. 2011
  4. ncbi Pregnancy and inflammatory bowel disease
    Uma Mahadevan
    Center for Colitis and Crohn s Disease, University of California, San Francisco, 2330 Post Street 610, San Francisco, CA 94115, USA
    Gastroenterol Clin North Am 38:629-49. 2009
  5. ncbi Gastrointestinal medications in pregnancy
    Uma Mahadevan
    Division of Gastroenterology, Department of Medicine, University of California, UCSF Center for Colitis and Crohn s Disease, 2330 Post Street 610, San Francisco, CA 94115, USA
    Best Pract Res Clin Gastroenterol 21:849-77. 2007
  6. ncbi Continuing immunomodulators and biologic medications in pregnant IBD patients - pro
    Uma Mahadevan
    UCSF Center for Colitis and Crohn's Disease, San Francisco, California, USA
    Inflamm Bowel Dis 13:1439-40. 2007
  7. ncbi Fertility and pregnancy in the patient with inflammatory bowel disease
    U Mahadevan
    Department of Medicine, University of California San Francisco, Center for Colitis and CD, 94115 USA
    Gut 55:1198-206. 2006
  8. ncbi Management of steroid-dependent ulcerative colitis: immunomodulatory agents, biologics, or surgery?
    Fernando Velayos
    Center for Colitis and Crohn s Disease, University of California, San Francisco, California 94118, USA
    Clin Gastroenterol Hepatol 5:668-71. 2007
  9. ncbi American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy
    Uma Mahadevan
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, USA
    Gastroenterology 131:283-311. 2006
  10. ncbi Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California
    Uma Mahadevan
    Division of Gastroenterology, Department of Medicine, University of California San Francisco, San Francisco, California 94115, USA
    Gastroenterology 133:1106-12. 2007

Detail Information

Publications27

  1. ncbi Management of inflammatory bowel disease in pregnancy
    Susie W Ng
    Department of Gastroenterology, University of California, San Francisco, CA 94122, USA
    Expert Rev Clin Immunol 9:161-73; quiz 174. 2013
    ....
  2. ncbi Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease
    Uma Mahadevan
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, California 94115, USA
    Clin Gastroenterol Hepatol 11:286-92; quiz e24. 2013
    ..It is not clear whether these drugs are transferred to the fetus via the placenta and then cleared, or whether structurally different TNF antagonists have different rates of transfer...
  3. ncbi The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics
    Uma Mahadevan
    Department of Gastroenterology, UCSF Center for Colitis and Crohn s Disease, San Francisco, California 94115, USA
    Am J Gastroenterol 106:214-23; quiz 224. 2011
    ..Inactivated vaccines may be safely administered to children with IBD, even when immunocompromised...
  4. ncbi Pregnancy and inflammatory bowel disease
    Uma Mahadevan
    Center for Colitis and Crohn s Disease, University of California, San Francisco, 2330 Post Street 610, San Francisco, CA 94115, USA
    Gastroenterol Clin North Am 38:629-49. 2009
    ..This review covers important questions that arise for physicians caring for women with inflammatory bowel disease. Fertility, pregnancy outcomes and the safety of medications in pregnancy and lactation are discussed...
  5. ncbi Gastrointestinal medications in pregnancy
    Uma Mahadevan
    Division of Gastroenterology, Department of Medicine, University of California, UCSF Center for Colitis and Crohn s Disease, 2330 Post Street 610, San Francisco, CA 94115, USA
    Best Pract Res Clin Gastroenterol 21:849-77. 2007
    ..The following medications should never be used during pregnancy due to the clear risk of teratogenicity or adverse events: bismuth, castor oil, sodium bicarbonate, methotrexate, ribavirin, doxycycline, tetracycline, and thalidomide...
  6. ncbi Continuing immunomodulators and biologic medications in pregnant IBD patients - pro
    Uma Mahadevan
    UCSF Center for Colitis and Crohn's Disease, San Francisco, California, USA
    Inflamm Bowel Dis 13:1439-40. 2007
  7. ncbi Fertility and pregnancy in the patient with inflammatory bowel disease
    U Mahadevan
    Department of Medicine, University of California San Francisco, Center for Colitis and CD, 94115 USA
    Gut 55:1198-206. 2006
  8. ncbi Management of steroid-dependent ulcerative colitis: immunomodulatory agents, biologics, or surgery?
    Fernando Velayos
    Center for Colitis and Crohn s Disease, University of California, San Francisco, California 94118, USA
    Clin Gastroenterol Hepatol 5:668-71. 2007
  9. ncbi American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy
    Uma Mahadevan
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, USA
    Gastroenterology 131:283-311. 2006
    ..The paper was approved by the Committee on February 22, 2006 and by the AGA Institute Governing Board on April 20, 2006...
  10. ncbi Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California
    Uma Mahadevan
    Division of Gastroenterology, Department of Medicine, University of California San Francisco, San Francisco, California 94115, USA
    Gastroenterology 133:1106-12. 2007
    ..The aim of this study was to determine whether pregnancy outcomes differ between women with and without inflammatory bowel disease (IBD) and to determine what risk factors adversely affect outcomes...
  11. ncbi Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications
    Uma Mahadevan
    Division of Gastroenterology, University of California, San Francisco, USA
    Inflamm Bowel Dis 8:311-6. 2002
    ..CONCLUSION: Early complications after restorative proctocolectomy for ulcerative colitis are associated with high dose steroids and severe disease but not use of azathioprine/6-mercaptopurine...
  12. ncbi 6TG: when less is more than you bargained for
    Uma Mahadevan
    UCSF Center for Colitis and Crohn's Disease, San Francisco, CA, USA
    Inflamm Bowel Dis 9:394-5. 2003
  13. ncbi Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease
    U Mahadevan
    Division of Gastroenterology, Department of Medicine, University of California San Francisco, CA 94115, USA
    Aliment Pharmacol Ther 21:733-8. 2005
    ..To study the effects of infliximab on pregnancy and foetal outcome...
  14. ncbi Fistula response to methotrexate in Crohn's disease: a case series
    U Mahadevan
    Division of Gastroenterology and Department of Medicine, University of California, San Francisco, CA, USA
    Aliment Pharmacol Ther 18:1003-8. 2003
    ..Controlled trials have demonstrated the efficacy of methotrexate in the induction and maintenance of remission in luminal Crohn's disease; however, its effect on fistulizing disease is unknown...
  15. ncbi TNF-alpha antagonists: benefits beyond remission
    Uma Mahadevan
    Department of Medicine, Center for Colitis and Crohn s Disease, University of California, San Francisco, San Francisco, California, USA
    Rev Gastroenterol Disord 7:S13-9. 2007
    ..With these tools, the goal of therapy in Crohn's disease may change from the management of symptoms to a change in the natural history of the disease...
  16. ncbi American gastroenterological association institute medical position statement on the use of gastrointestinal medications in pregnancy
    Uma Mahadevan
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, USA
    Gastroenterology 131:278-82. 2006
    ..quot; It was approved by the Clinical Practice and Economics Committee on February 22, 2006, and by the AGA Institute Governing Board on April 20, 2006...
  17. ncbi Infliximab and semen quality in men with inflammatory bowel disease
    Uma Mahadevan
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, California 94115, USA
    Inflamm Bowel Dis 11:395-9. 2005
    ..There is no available data on the effects of infliximab on semen quality. The aim of this study was to determine whether changes in semen quality occurred in men receiving infliximab...
  18. ncbi Cytokine profiles in peripheral blood of children and adults with Crohn disease
    Seung Pak
    School of Public Health, University of California, Berkeley, CA, USA
    J Pediatr Gastroenterol Nutr 54:769-75. 2012
    ..The present pilot study examines the hypothesis that cytokine profiles differ between pediatric and adult patients with CD...
  19. ncbi Transitioning the adolescent inflammatory bowel disease patient: guidelines for the adult and pediatric gastroenterologist
    Yvette Leung
    Department of Medicine, Division of Gastroenterology, University of Calgary, Canada
    Inflamm Bowel Dis 17:2169-73. 2011
    ....
  20. ncbi Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease
    Uma Mahadevan
    Division of Gastroenterology and Hepatology, University of California, San Francisco, 55905, USA
    Am J Gastroenterol 97:910-4. 2002
    ..CONCLUSIONS: Our preliminary results suggest that cyclooxygenase-2 inhibitors may be safe and beneficial in most patients with IBD. A placebo-controlled trial to confirm these preliminary observations is needed...
  21. ncbi Diagnosis and management of pouchitis
    Uma Mahadevan
    Department of Medicine, University of California, San Fancisco, USA
    Gastroenterology 124:1636-50. 2003
  22. ncbi Infliximab for the treatment of orofacial Crohn's disease
    U Mahadevan
    Department of Medicine, University of California San Francisco, USA
    Inflamm Bowel Dis 7:38-42. 2001
    ..A review of the literature of the orofacial granulomatoses is presented as well...
  23. ncbi Micronutrient deficiencies in inflammatory bowel disease: from A to zinc
    Caroline Hwang
    Division of Gastroenterology, University of California, San Francisco, California, USA
    Inflamm Bowel Dis 18:1961-81. 2012
    ....
  24. ncbi Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis
    Christian Mathy
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco 94115, USA
    Inflamm Bowel Dis 9:351-5. 2003
    ..To devise rational cancer surveillance guidelines, further studies are needed to determine the risk of colitis-related neoplasia in patients with microscopic pancolitis but limited gross disease...
  25. ncbi Infliximab for the treatment of metastatic hepatic and pulmonary Crohn's disease
    Kanwar R S Gill
    Inflamm Bowel Dis 11:210-2. 2005
  26. ncbi A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis
    Scott Plevy
    Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA
    Gastroenterology 133:1414-22. 2007
    ....
  27. ncbi Mucosal healing in Crohn's disease: what you see is what you get?
    Uma Mahadevan
    Gastrointest Endosc 63:443-4. 2006